(Q28291658)

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The mechanisms of DNA topoisomerases

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The DNA damage response: putting checkpoints in perspective

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The many substrates and functions of ATM

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Substrate specificities and identification of putative substrates of ATM kinase family members

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401843

21 April 2017

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Activators and target genes of Rel/NF-kappaB transcription factors

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Shaping the nuclear action of NF-kappaB

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

IkappaB kinases: key regulators of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Evidence that reactive oxygen species do not mediate NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Cyclobutane pyrimidine dimers in UV-DNA induce release of soluble mediators that activate the human immunodeficiency virus promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

The ATM protein is required for sustained activation of NF-kappaB following DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Transcriptional cross talk between NF-kappaB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Modulation of NF-kappaB activity by exchange of dimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

NF-kappaB: tumor promoter or suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

Is NF-kappaB the sensor of oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

NF-kappa B activation by ultraviolet light not dependent on a nuclear signal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

The DNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

1 reference

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021

PIDD mediates NF-kappaB activation in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401843

7 January 2021